Wall Street’s main indexes closed lower on Friday, with the S&P 500 and Nasdaq notching their biggest one-day losses in two weeks, on concerns about slower interest-rate cuts and as …
By Nicole Ireland and Hannah Alberga The Canadian Press Posted September 24, 2024 12:40 pm 1 min read Descrease article font size Increase article font size Health Canada has approved …
Home Technology Mice With Functional Humanised Immune System Shows Promise To date, researchers have not developed a fully functional human immune system. (Representational image: www.pexels.com) New Delhi: A first-of-its-kind mice …
Kansas AG Kris Kobach: Pfizer violated state Consumer Protection Act Pfizer: Case has ‘no merit’ and company will respond in ‘due course’ Dr. John Moore: Political vaccine misinformation deadly to …
(NewsNation) — The state of Kansas has sued the pharmaceutical company Pfizer, accusing it of misleading the public about its COVID-19 vaccine by making false claims about its effectiveness. In the …
Pfizer has announced findings from the Phase II MagnetisMM-3 clinical trial of ELREXFIO (elranatamab-bcmm) in patients with relapsed or refractory multiple myeloma (RRMM), who are heavily pretreated. ELREXFIO is a …
Descrease article font size Increase article font size Pfizer on Wednesday forecast 2024 sales that were as much as $5 billion below Wall Street expectations due mostly to declining demand …
Moderna should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its COVID vaccine to …
Pfizer on Tuesday urged investors to focus on growth in its non-COVID products such as its new RSV vaccine Abrysvo, after weak demand for its COVID-19 vaccine and treatment pushed …
The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag. Pharmaceutical giant Pfizer is …